南财智讯2月26日电，长阳科技发布2025年度业绩快报，报告期内公司实现营业收入10.79亿元，同比下 降19.24%；归属于上市公司股东的净利润-1.45亿元；基本每股收益-0.50元。 ...

Core Insights - The investment landscape in the energy storage sector is shifting significantly, driven by the dual forces of energy transition and the explosion of AI computing power. This has led to a fundamental change in the investment logic of the energy storage industry [1][4][16]. Group 1: Institutional Holdings - Major foreign institutions such as Goldman Sachs and Morgan Stanley have recently entered the top shareholder lists of several companies, indicating a strong collective interest in the energy storage sector [2][8]. - Goldman Sachs and Morgan Stanley have made significant new investments in companies like Kosen Technology and Highlan, reflecting a trend of foreign capital focusing on key players in the energy storage supply chain [2][8]. Group 2: Policy Changes - A milestone policy was introduced in January 2026, integrating new energy storage into the capacity pricing system, allowing independent storage stations to earn fixed capacity fees, thus transforming the business model of energy storage [4][16]. - This policy change positions energy storage as an independent profit-generating entity rather than merely a cost component associated with renewable energy [4][16]. Group 3: Market Demand - The demand for energy storage is being propelled by the increasing electricity consumption of global data centers, particularly those driven by AI, which is expected to reach 800-1100 TWh by 2026, a significant increase from 2022 [5][6]. - The energy storage industry is projected to see a 62% year-on-year growth in new installations globally, with China expected to reach 250 GWh in new installations, marking a 67% growth [6][16]. Group 4: Company Profiles - Kosen Technology is recognized for its leading solid-state battery packaging technology, which significantly reduces thermal runaway risks and is expected to capture a substantial share of the solid-state battery packaging market [8][12]. - Highlan is a key supplier in the liquid cooling temperature control sector for energy storage, with a market share of approximately 15%, and is positioned to benefit from the shift towards liquid cooling technologies in AI data centers [10][12]. - Hande Electric is involved in both pumped storage and electrochemical energy storage, providing critical components for energy transmission and battery materials [10][12]. - Zhongdian Xinlong focuses on energy storage system integration and liquid cooling solutions, with a strong emphasis on long-duration energy storage technologies [12][16]. - Leshan Electric operates energy storage assets directly, showcasing a stable business model that encompasses the entire lifecycle from investment to operation [12][16]. - Huazi Technology specializes in energy storage system integration and core equipment development, covering various market segments [12][16]. - Changyang Technology is a key supplier of membrane materials for energy storage and power batteries, with a focus on solid-state battery materials [14][16]. - Yangdian Technology provides specialized transformers and energy conversion equipment for energy storage systems, ensuring stable demand regardless of technological changes [14][16]. Group 5: Industry Trends - The energy storage sector is rapidly evolving, with large-capacity battery cells becoming mainstream and the average discharge duration of storage systems increasing from 2.3 hours to 2.58 hours by the end of 2025 [16]. - Liquid cooling technology is replacing traditional air cooling methods, indicating a shift towards more efficient thermal management solutions in energy storage systems [16].

本次会议是否有被否决议案：无 一、 会议召开和出席情况 证券代码：688299 证券简称：长阳科技 公告编号：2026-009 宁波长阳科技股份有限公司 2026年第一次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： （一） 股东会召开的时间：2026 年 2 月 25 日 （二） 股东会召开的地点：宁波市江北区庆丰路 999 号公司一楼会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 168 | | --- | --- | | 普通股股东人数 | 168 | | 2、出席会议的股东所持有的表决权数量 | 57,496,821 | | 普通股股东所持有表决权数量 | 57,496,821 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 20.3679 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 20.3679 | （四） 表决方式 ...

国浩律师（上海）事务所 法律意见书 国浩律师（上海）事务所 Grandall Law Firm (Shanghai) 中国 上海 上海市静安区山西北路 99 号苏河湾中心 MT25-28 楼，200085 25-28/F, Suhe Centre, 99 North Shanxi Road, Jing'an District, Shanghai, China, 200085 致：宁波长阳科技股份有限公司 国浩律师（上海）事务所（以下简称"本所"）接受宁波长阳科技股份有限 公司（以下简称"公司"）委托，指派本所律师出席公司 2026 年第一次临时股 东会（以下简称"本次股东会"）。本所律师根据《中华人民共和国证券法》（以 下简称"《证券法》"）、《中华人民共和国公司法》（以下简称"《公司法》"）、 《上市公司股东会规则》（以下简称"《股东会规则》"）等法律、法规、部门 规章和规舃性文件以及《宁波长阳科技股份有限公司章程》（以下简称"《公司 章程》"）的规定，就公司本次股东会的召集与召开程序、出席会议人员资格、 召集人资格、会议表决程序和表决结果的合法性等有关法律问题出具法律意见书。 对本法律意见书的出具，本所律 ...

Core Viewpoint - Recently, Fosun Pharma announced that its subsidiary, Fuhong Hanlin, received approval from the National Medical Products Administration to conduct Phase I clinical trials for HLX15-SC, a recombinant anti-CD38 fully human monoclonal antibody injection for the treatment of multiple myeloma [1] Group 1: Clinical Development - Fuhong Hanlin plans to conduct relevant clinical research for HLX15 in China once conditions are met [1] - HLX15 is a biosimilar to Daratumumab, with both subcutaneous (HLX15-SC) and intravenous (HLX15-IV) formulations intended for the treatment of multiple myeloma [1] Group 2: Financial Investment - As of January 2026, the company's cumulative R&D investment is approximately 192 million yuan [1] - According to the latest data, the global sales of Daratumumab formulations are expected to reach approximately 12.882 billion USD in 2024 [1]

Core Viewpoint - Changyang Technology plans to terminate its "annual production of 30 million square meters of high-end optical deep processing film project" due to intense market competition and unsatisfactory investment returns, with the board's approval pending shareholder meeting confirmation [1] Group 1: Project Termination - The decision to terminate the high-end optical film project has been approved by the board and awaits shareholder approval [1] - The company cites fierce market competition and poor investment returns as the primary reasons for this decision [1] Group 2: Financial Performance - Changyang Technology expects a net profit loss of between 116 million yuan and 168 million yuan for 2025, attributed to intensified product market competition and asset impairment losses [2] Group 3: Corporate Actions - A temporary shareholder meeting is scheduled for February 25, 2026, to review the termination of the project and the guarantee proposal, utilizing both in-person and online voting methods [3] - The company has decided to permanently supplement working capital with approximately 22.81 million yuan of surplus funds from its initial public offering investment projects to optimize account management [3]

Group 1 - The core viewpoint of the article is that Changyang Technology (688299.SH) has stated there are currently no plans for mergers and acquisitions [1]

Core Viewpoint - Changyang Technology (688299.SH) is accelerating the development and validation of its CPI film project, which involves transparent polyimide films [1] Group 1: Project Development - The company is currently constructing its CPI project and aims to expedite the development and validation of CPI films [1] - The solid or semi-solid battery electrolyte composite membrane, known as the skeleton membrane, has received orders from leading domestic and international clients [1] Group 2: Market Demand and Financial Impact - The market demand for the skeleton membrane product has not yet ramped up, resulting in a small revenue amount [1] - The short-term financial impact on the company's operating performance is expected to be minimal [1] Group 3: Ongoing Developments - The ion-conducting membrane that the company is developing is still in the validation phase [1]

Core Viewpoint - The strong trend in the mainland healthcare sector from last year is expected to continue into this year, with investors considering the value of more R&D pipelines when evaluating valuations [1] Group 1: Investment Strategy - Companies are now trading based more on actual execution capabilities rather than solely on licensing deal expectations [1] - Achieving returns that exceed the industry average this year will rely more on key data releases, actual transactions, and visibility on profit realization or turning points [1] Group 2: Sector Analysis - The outlook for CDMO companies is becoming more constructive due to accelerated growth, strong product cycles, limited geopolitical risks, and reasonable valuations [1] - The ratings for WuXi AppTec and WuXi AppTec Holdings have been upgraded to "Buy" [1] Group 3: Selective Strategy in Biotech and Pharma - A selective strategy is adopted for biotech and pharmaceutical companies, favoring those with key data releases and early data showing some promise, along with actual transaction expectations [1] - Companies such as Kelun-Biotech, Innovent Biologics, and Hansoh Pharmaceutical are viewed positively [1] Group 4: Medical Devices Sector - The medical devices sector maintains a neutral outlook, as the industry has bottomed out but requires time for gradual recovery [1] - Recommendations include buying Angelalign Technology and Weigao Group [1]

宁波长阳科技股份有限公司 2026 年第一次临时股东会会议资料 证券代码：688299 证券简称：长阳科技 宁波长阳科技股份有限公司 2026 年第一次临时股东会会议资料 2026 年 2 月 宁波长阳科技股份有限公司 2026 年第一次临时股东会会议资料 宁波长阳科技股份有限公司 2026 年第一次临时股东会会议资料目录 | 宁波长阳科技股份有限公司 年第一次临时股东会会议须知 2026 | 1 | | --- | --- | | 宁波长阳科技股份有限公司 2026 年第一次临时股东会会议议程 | 3 | | 议案一：关于终止超募资金投资项目的议案 | 5 | | 议案二：关于为全资子公司向银行申请综合授信额度提供担保的议案 | 12 | 宁波长阳科技股份有限公司 2026 年第一次临时股东会会议资料 宁波长阳科技股份有限公司 2026 年第一次临时股东会会议须知 为了维护全体股东的合法权益，确保股东会的正常秩序和议事效率，保证大 会的顺利进行，根据《中华人民共和国公司法》《中华人民共和国证券法》《上市 公司股东会规则》以及《宁波长阳科技股份有限公司章程》、《宁波长阳科技股份 有限公司股东会议事规则》等相关 ...